CN103816505A - Medicine for treating disease of prostate - Google Patents
Medicine for treating disease of prostate Download PDFInfo
- Publication number
- CN103816505A CN103816505A CN201310723612.9A CN201310723612A CN103816505A CN 103816505 A CN103816505 A CN 103816505A CN 201310723612 A CN201310723612 A CN 201310723612A CN 103816505 A CN103816505 A CN 103816505A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- rhizoma
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating the disease of prostate. The medicine is a medicine composition which is prepared by taking purely natural plants, animals and minerals as raw materials, and elaborately processing according to a certain technology. The medicine has notable curative effects on chronic prostatitis, hyperplasia of prostate, prostatomegaly and the like caused by the disease of prostate; the diseases of prostate can be thoroughly healed and cannot recrudesce after cure, and no toxic or side effects exist; at the same time, the sources of the raw materials used by the medicine provided by the invention are extensive so that the medicine is low in cost, the preparation method of the medicine is simple, and environment is not polluted in the production of the medicine.
Description
Affiliated technical field
The invention discloses a kind of medicine for the treatment of prostatosis, belong to Chinese medicine technical field.
Background technology
Prostatosis is commonly encountered diseases, the frequently-occurring disease of the prime of life, elderly men, comprise the diseases such as chronic prostatitis, prostatic hyperplasia, prostate hyperplasia, the wherein multiple postadolescent of being born in of chronic prostatitis, prostatic hyperplasia, loose disease be multiple is born in old people, once it is just very painful that patient suffers from prostatosis, postadolescent can be because there are paruria, frequent micturition, dysurea, sexual dysfunction etc. in chronic prostatitis; Old people suffers from prostatic hyperplasia, causes dysuria, frequent micturition, nocturia increase, urine blocks, urine retention, the dripping symptoms such as renal failure that not to the utmost, even cause.The medicament categories that is used for the treatment of at present prostatosis is various, has Chinese patent medicine class, Western medicine class, also has Chinese medicine and western medicine composition of medicine class etc., although these class medicines can have certain curative effect to prostatosis, but unsatisfactory curative effect, can not effect a radical cure, only can play interim mitigation; Once drug withdrawal, the state of an illness will rebound, and this patient brings lifelong misery.Now, also there is no a kind of medicine that can effect a radical cure prostatosis.
Summary of the invention
The object of the invention is openly a kind of medicine for the treatment of prostatosis, with this Drug therapy prostatosis, not only treatment time is short, curative effect is high but also can effect a radical cure, and non-relapse after healing, is the desirable medicine of prostate patient.The medicine of this treatment prostatosis is that to adopt pure natural plant, animal, mineral be the pharmaceutical composition that raw material is prepared from; In medicine of the present invention raw material used, what come from plant is the Radix Rehmanniae, Radix Rehmanniae Preparata, Poria, Semen Plantaginis, Herba Violae, Cortex Moutan, Cortex Cinnamomi, Radix Aconiti Lateralis Preparata, Rhizoma Zingiberis, the Radix Astragali, Radix Paeoniae Rubra, Radix Angelicae Sinensis, SHANZHIZI, Fructus Forsythiae, Radix Saposhnikoviae, Herba Schizonepetae, Flos Lonicerae, Radix Platycodonis, Polyporus, Caulis Akebiae, Fructus Aurantii, Semen Pharbitidis, Radix Et Rhizoma Rhei, the Radix Angelicae Dahuricae, Rhizoma Sparganii, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, Rhizoma Polygoni Cuspidati, Radix Notoginseng, Fructus Psoraleae, Spica Prunellae, Semen Vaccariae; What come from animal is Scorpio, Scolopendra, Bombyx Batryticatus, Periostracum Cicadae, process of preparing Chinese medicine Squama Manis, Agkistrodon, Pheretima, Eupolyphaga Seu Steleophaga, Hirudo, Cornu Cervi tablet; What come from mineral is Natrii Sulfas, and the consumption of various raw materials is respectively by weight:
150~200 parts, the Radix Rehmanniae, 150~200 parts, Radix Rehmanniae Preparata, 150~200 parts, Poria, 150~200 parts of Semen Plantaginiss, 150~200 parts of Herba Violaes, 150~200 parts of Cortex Moutans, 100~150 parts of Cortex Cinnamomis, 100~150 parts of Radix Aconiti Lateralis Preparata, 100~150 parts of Rhizoma Zingiberiss, 150~200 parts of the Radixs Astragali, 150~200 parts of Radix Paeoniae Rubra, 300~350 parts of Radix Angelicae Sinensis, 150~200 parts of SHANZHIZI, 150~200 parts of Fructus Forsythiaes, 150~200 parts of Radix Saposhnikoviaes, 150~200 parts of Herba Schizonepetae, 450~500 parts of Flos Loniceraes, 150~200 parts of Radix Platycodoniss, 150~200 parts of Polyporus, 150~200 parts of Caulis Akebiaes, 150~200 parts of Fructus Aurantiis, 150~200 parts of Semen Pharbitidiss, 150~200 parts of Radix Et Rhizoma Rhei, 150~200 parts of the Radixs Angelicae Dahuricae, 150~200 parts of Rhizoma Sparganii, 150~200 parts of 150~200 portions of Bulbus Fritillariae Uninbracteataes of Spina Gleditsiae, 150~200 parts of Rhizoma Polygoni Cuspidati, 150~200 parts, Radix Notoginseng, 150~200 parts of Fructus Psoraleaes, 150~200 parts of Spica Prunellaes, 150~200 parts of Semen Vaccariae, 150~200 parts of Scorpio, 150~200 parts of Scolopendras, 150~200 parts of Bombyx Batryticatus, 150~200 parts of Periostracum Cicadaes, 100~150 parts of Agkistrodons, concoct 150~200 parts of Squama Maniss, 150~200 parts of Pheretimas, 150~200 parts of Eupolyphaga Seu Steleophagas, 150~200 parts of Hirudos, 150~200 parts of Cornu Cervi tablets, 150~200 parts, Natrii Sulfas.
The present invention also discloses the preparation method of this pharmaceutical composition.
Medicine of the present invention proves there is significant curative effect for prostatosis such as chronic prostatitis, prostatic hyperplasia, prostate hyperplasia through a large amount of clinical practices, during treatment and without any side effects after curing, is the ideal medicine for the treatment of prostatosis.
Now lift the effect of some example explanations medicine of the present invention:
Chapter so-and-so, man, 35 years old, live No. 15, Jianshe Road, Pingdingshan City, Henan Province, when this person 30 years old, suffer from chronic prostatitis, waist soft unable, perineal position is moist, paruria, sexual life is too short, premature ejaculation is unable, therefore thing family discord.Successively took the prostatic medicine of multiple treatment, but poor effect.On April 15th, 2011 starts to take medicine of the present invention, takes 7 days, and perineal position humidity alleviates, and takes 15 days moist disappearances of perineal position, waist is warm energetically, and the normal of urinating is taken medicine and thoroughly cured for 60 days, above-mentioned symptom disappears completely, gets back to again the health status of more than 20 year old, follows up a case by regular visits to so far no recurrence.Similar these class patient 503 examples, cure 503 examples.
Yang, man, 69 years old, lives workers and peasants road, Jiyuan City, Henan Province No. 121.This person is driver, prostatoplasia diseases was suffered from irregular, the sitting of often having a meal in the time of 40 years old, when the initial stage, urinate thin, the time is long, perineum place gives out abnormal flavour, simultaneously often say that he does not have a bath, dirty from head to foot, developed afterwards dysuria, all arrange unclean half an hour, patient suffering can't bear, and successively takes the medicine of multiple treatment prostatic hyperplasia, but poor effect.On July 25th, 2003 starts to take medicine of the present invention, takes 8 days, and perineal position abnormal flavour alleviates, and takes 15 days perineal position abnormal flavour and disappears, the improvement of urinating; Take 30 days normals of urinating, take medicine and thoroughly cure for 60 days, follow up a case by regular visits to so far and do not recur.Treat similar this case and reach 305 people, cure 303 people, other 2 human therapies take a turn for the better rear because not getting in touch with to other places.
Close certain, man 77 years old, lives Guangming Road, Zhumadian City, Henan Province No. 169.This person suffered from prostatoplasia diseases in the time of 62 years old, urination time is long, developed into afterwards prostate hyperplasia, urinate difficult especially, half a day is dripping unclean, and patient suffering can't bear, the suggestion of hospital treatment school is performed an operation, close certain and do not agree to, adopt injection antibiotic medicine, coordinate drug administration expectant treatment, but poor effect.Within 2000, JIUYUE starts to take medicine of the present invention on 9th, take 10 days, and the improvement of urinating, taking urinates for 20 days takes a favorable turn, and takes 40 days normals of urinating, and takes medicine and thoroughly cures for 60 days, and prostate hyperplasia disappears on inspection, follows up a case by regular visits to so far and does not recur.Treat similar this case and reach 186 people, cure 185 people, other 1 people are because myocardial infarction is to dead.
The remarkable advantage of medicine of the present invention is that treatment prostatosis is effective, can effect a radical cure the diseases such as chronic prostatitis that prostatosis causes, prostatic hyperplasia, loose disease, and not only curative effect is high, and have no side effect, no dependence, do not recur after more; The present invention also has the advantages such as preparation method is simple, raw material is easy to get, with low cost.
The preparation method of medicine of the present invention is as follows:
Get 150~200 parts, the Radix Rehmanniae, 150~200 parts, Radix Rehmanniae Preparata, 150~200 parts, Poria, 150~200 parts of Semen Plantaginiss, 150~200 parts of Herba Violaes, 150~200 parts of Cortex Moutans, 100~150 parts of Cortex Cinnamomis, 100~150 parts of Radix Aconiti Lateralis Preparata, 100~150 parts of Rhizoma Zingiberiss, 150~200 parts of the Radixs Astragali, 150~200 parts of Radix Paeoniae Rubra, 300~350 parts of Radix Angelicae Sinensis, 150~200 parts of SHANZHIZI, 150~200 parts of Fructus Forsythiaes, 150~200 parts of Radix Saposhnikoviaes, 150~200 parts of Herba Schizonepetae, 450~500 parts of Flos Loniceraes, 150~200 parts of Radix Platycodoniss, 150~200 parts of Polyporus, 150~200 parts of Caulis Akebiaes, 150~200 parts of Fructus Aurantiis, 150~200 parts of Semen Pharbitidiss, 150~200 parts of Radix Et Rhizoma Rhei, 150~200 parts of the Radixs Angelicae Dahuricae, 150~200 parts of Rhizoma Sparganii, 150~200 parts of 150~200 portions of Bulbus Fritillariae Uninbracteataes of Spina Gleditsiae, 150~200 parts of Rhizoma Polygoni Cuspidati, 150~200 parts, Radix Notoginseng, 150~200 parts of Fructus Psoraleaes, 150~200 parts of Spica Prunellaes, 150~200 parts of Semen Vaccariae, 150~200 parts of Scorpio, 150~200 parts of Scolopendras, 150~200 parts of Bombyx Batryticatus, 150~200 parts of Periostracum Cicadaes, 100~150 parts of Agkistrodons, concoct 150~200 parts of Squama Maniss, 150~200 parts of Pheretimas, 150~200 parts of Eupolyphaga Seu Steleophagas, 150~200 parts of Hirudos, 150~200 parts of Cornu Cervi tablets, 150~200 parts, Natrii Sulfas is ground into segmentation, makes pill, tablet, capsule all can.
Specific embodiments
Further describe technical characterictic of the present invention below in conjunction with embodiment:
Embodiment 1
Get Radix Rehmanniae 150g, Radix Rehmanniae Preparata 150g, Poria 150g, Semen Plantaginis 150g, Herba Violae 150g, Cortex Moutan 150g, Cortex Cinnamomi 100g, Radix Aconiti Lateralis Preparata 100g, Rhizoma Zingiberis 100g, Radix Astragali 150g, Radix Paeoniae Rubra 150g, Radix Angelicae Sinensis 300g, SHANZHIZI 150g, Fructus Forsythiae 150g, Radix Saposhnikoviae 150g, Herba Schizonepetae 150g, Flos Lonicerae 450g, Radix Platycodonis 150g, Polyporus 150g, Caulis Akebiae 150g, Fructus Aurantii 150g, Semen Pharbitidis 150g, Radix Et Rhizoma Rhei 150g, Radix Angelicae Dahuricae 150g, Rhizoma Sparganii 150g, Spina Gleditsiae 150g, Bulbus Fritillariae Uninbracteatae 150g, Rhizoma Polygoni Cuspidati 150g, Radix Notoginseng 150g, Fructus Psoraleae 150g, Spica Prunellae 150g, Semen Vaccariae 150g, Scorpio 150g, Scolopendra 150g, Bombyx Batryticatus 150g, Periostracum Cicadae 150g, Agkistrodon 100g, concoct Squama Manis 150g, Pheretima 200g, Eupolyphaga Seu Steleophaga 200g, Hirudo 150g, Cornu Cervi 200g, Natrii Sulfas 150g is ground into segmentation, make pill and get final product.
The present invention is raw materials used is all products of having concocted on market.
Claims (2)
1. treat the medicine (the infirmity gland medicine bolus for recuperating of Pan Shi) of prostatosis for one kind, it is characterized in that: the medicine of described treatment prostatosis is to be prepared from by the raw material of following weight portion:
150~200 parts, the Radix Rehmanniae, 150~200 parts, Radix Rehmanniae Preparata, 150~200 parts, Poria, 150~200 parts of Semen Plantaginiss, 150~200 parts of Herba Violaes, 150~200 parts of Cortex Moutans, 100~150 parts of Cortex Cinnamomis, 100~150 parts of Radix Aconiti Lateralis Preparata, 100~150 parts of Rhizoma Zingiberiss, 150~200 parts of the Radixs Astragali, 150~200 parts of Radix Paeoniae Rubra, 300~350 parts of Radix Angelicae Sinensis, 150~200 parts of SHANZHIZI, 150~200 parts of Fructus Forsythiaes, 150~200 parts of Radix Saposhnikoviaes, 150~200 parts of Herba Schizonepetae, 450~500 parts of Flos Loniceraes, 150~200 parts of Radix Platycodoniss, 150~200 parts of Polyporus, 150~200 parts of Caulis Akebiaes, 150~200 parts of Fructus Aurantiis, 150~200 parts of Semen Pharbitidiss, 150~200 parts of Radix Et Rhizoma Rhei, 150~200 parts of the Radixs Angelicae Dahuricae, 150~200 parts of Rhizoma Sparganii, 150~200 parts of 150~200 portions of Bulbus Fritillariae Uninbracteataes of Spina Gleditsiae, 150~200 parts of Rhizoma Polygoni Cuspidati, 150~200 parts, Radix Notoginseng, 150~200 parts of Fructus Psoraleaes, 150~200 parts of Spica Prunellaes, 150~200 parts of Semen Vaccariae, 150~200 parts of Scorpio, 150~200 parts of Scolopendras, 150~200 parts of Bombyx Batryticatus, 150~200 parts of Periostracum Cicadaes, 100~150 parts of Agkistrodons, concoct 150~200 parts of Squama Maniss, 150~200 parts of Pheretimas, 150~200 parts of Eupolyphaga Seu Steleophagas, 150~200 parts of Hirudos, 150~200 parts of Cornu Cervi tablets, 150~200 parts, Natrii Sulfas.
2. by the preparation method of the medicine (the infirmity gland medicine bolus for recuperating of Pan Shi) for the treatment of prostatosis claimed in claim 1, it is characterized in that, described preparation method is:
Get 150~200 parts, the Radix Rehmanniae, 150~200 parts, Radix Rehmanniae Preparata, 150~200 parts, Poria, 150~200 parts of Semen Plantaginiss, 150~200 parts of Herba Violaes, 150~200 parts of Cortex Moutans, 100~150 parts of Cortex Cinnamomis, 100~150 parts of Radix Aconiti Lateralis Preparata, 100~150 parts of Rhizoma Zingiberiss, 150~200 parts of the Radixs Astragali, 150~200 parts of Radix Paeoniae Rubra, 300~350 parts of Radix Angelicae Sinensis, 150~200 parts of SHANZHIZI, 150~200 parts of Fructus Forsythiaes, 150~200 parts of Radix Saposhnikoviaes, 150~200 parts of Herba Schizonepetae, 450~500 parts of Flos Loniceraes, 150~200 parts of Radix Platycodoniss, 150~200 parts of Polyporus, 150~200 parts of Caulis Akebiaes, 150~200 parts of Fructus Aurantiis, 150~200 parts of Semen Pharbitidiss, 150~200 parts of Radix Et Rhizoma Rhei, 150~200 parts of the Radixs Angelicae Dahuricae, 150~200 parts of Rhizoma Sparganii, 150~200 parts of 150~200 portions of Bulbus Fritillariae Uninbracteataes of Spina Gleditsiae, 150~200 parts of Rhizoma Polygoni Cuspidati, 150~200 parts, Radix Notoginseng, 150~200 parts of Fructus Psoraleaes, 150~200 parts of Spica Prunellaes, 150~200 parts of Semen Vaccariae, 150~200 parts of Scorpio, 150~200 parts of Scolopendras, 150~200 parts of Bombyx Batryticatus, 150~200 parts of Periostracum Cicadaes, 100~150 parts of Agkistrodons, concoct 150~200 parts of Squama Maniss, 150~200 parts of Pheretimas, 150~200 parts of Eupolyphaga Seu Steleophagas, 150~200 parts of Hirudos, 150~200 parts of Cornu Cervi tablets, 150~200 parts, Natrii Sulfas is ground into segmentation, makes pill, tablet, capsule all can.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310723612.9A CN103816505A (en) | 2013-12-14 | 2013-12-14 | Medicine for treating disease of prostate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310723612.9A CN103816505A (en) | 2013-12-14 | 2013-12-14 | Medicine for treating disease of prostate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103816505A true CN103816505A (en) | 2014-05-28 |
Family
ID=50751985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310723612.9A Pending CN103816505A (en) | 2013-12-14 | 2013-12-14 | Medicine for treating disease of prostate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103816505A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079657A (en) * | 2015-09-07 | 2015-11-25 | 康莉 | Traditional Chinese medicine for treating benign prostatic hyperplasia with syndrome of sinking of qi of middle-jiao |
CN107007734A (en) * | 2017-05-26 | 2017-08-04 | 毛里夏里甫·哈帕 | A kind of medicine for treating gynaecological disease, prostatic disorders and preparation method thereof and application method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169308A (en) * | 1996-06-29 | 1998-01-07 | 郭万启 | Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone |
EP1553972B1 (en) * | 2002-10-11 | 2010-10-13 | Milkhaus Laboratory, Inc. | Chorionic gonadotropin for use in the treatment of chronic pelvic pain syndrome |
-
2013
- 2013-12-14 CN CN201310723612.9A patent/CN103816505A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169308A (en) * | 1996-06-29 | 1998-01-07 | 郭万启 | Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone |
EP1553972B1 (en) * | 2002-10-11 | 2010-10-13 | Milkhaus Laboratory, Inc. | Chorionic gonadotropin for use in the treatment of chronic pelvic pain syndrome |
Non-Patent Citations (3)
Title |
---|
国家药典委员会: "《中华人民共和国药典2010版 一部》", 31 January 2010, 中国医药科技出版社 * |
夏东胜: "中国药典2010版毒性药材使用禁忌与毒性控制", 《中国现代应用药学》 * |
张伯礼,等: "《组分配伍研制现代中药的理论与实践:方剂关键科学问题的基础研究》", 31 October 2010, 辽宁科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079657A (en) * | 2015-09-07 | 2015-11-25 | 康莉 | Traditional Chinese medicine for treating benign prostatic hyperplasia with syndrome of sinking of qi of middle-jiao |
CN107007734A (en) * | 2017-05-26 | 2017-08-04 | 毛里夏里甫·哈帕 | A kind of medicine for treating gynaecological disease, prostatic disorders and preparation method thereof and application method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102920984A (en) | Medicine for curing rheumatoid arthritis | |
CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
CN103330806B (en) | Drug for treatment of rheumatoid arthritis | |
CN104161868A (en) | Drug for treating rheumatoid arthritis | |
CN101897879B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
CN102091141A (en) | Medicament for treating gout and preparation method thereof | |
CN103816505A (en) | Medicine for treating disease of prostate | |
CN104162088A (en) | Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof | |
CN106860659A (en) | A kind of composition for treating cold acute filthy disease disease and preparation method thereof | |
CN103735956B (en) | The medicine for the treatment of cervical cancer | |
CN102631450A (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
CN102205096A (en) | Medicament for treating adnexitis and pelvic inflammation | |
CN103212009A (en) | Medicine for treating cardiovascular and cerebtovascular diseases | |
CN104248677A (en) | Traditional Chinese medicinal preparation for treating erythema multiforme | |
CN103860952A (en) | Traditional Chinese medicine lotion for treating vulva pruritus | |
CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
CN101912570A (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
CN1183918C (en) | Medicine for curing protrution of intervetebral disc and its preparing method | |
CN102861245A (en) | Medicine for preventing and treating gout disease | |
CN104984166A (en) | Care medicine for treating eczema scroti and preparing method thereof | |
CN1724021A (en) | Traditional Chinese medicine for treating rheumatoid disease | |
CN103656487A (en) | Traditional Chinese medicine composition for treating colonitis | |
CN104161861A (en) | Traditional Chinese medicine for treating senile constipation | |
CN103585530B (en) | Traditional Chinese medicine composition for treating psoriasis | |
CN101569728B (en) | Pharmaceutical composition for treating urticaria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140528 |
|
WD01 | Invention patent application deemed withdrawn after publication |